| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0140-6736(08)60602-9 |
| P698 | PubMed publication ID | 18501419 |
| P50 | author | Rudi Westendorp | Q27070673 |
| Anton J M de Craen | Q86207930 | ||
| Peter W Macfarlane | Q90553715 | ||
| Ian Ford | Q91610546 | ||
| Dilys Freeman | Q91941265 | ||
| David J Stott | Q92190716 | ||
| S Goya Wannamethee | Q114322614 | ||
| Naveed Sattar | Q37378984 | ||
| Peter H. Whincup | Q37390434 | ||
| Nita G. Forouhi | Q37625061 | ||
| Lucy T. Lennon | Q43983894 | ||
| Alex McConnachie | Q59393321 | ||
| J Wouter Jukema | Q64858750 | ||
| P2093 | author name string | Brendan M Buckley | |
| Chris J Packard | |||
| James Shepherd | |||
| Michael B Murphy | |||
| Gerard J Blauw | |||
| A Gerald Shaper | |||
| P2860 | cites work | Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation | Q29547453 |
| Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial | Q29617817 | ||
| Blood pressure and mortality in elderly people aged 85 and older: community based study. | Q33802130 | ||
| The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes | Q33989576 | ||
| Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease? | Q34361973 | ||
| Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies | Q34574433 | ||
| Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker | Q35754449 | ||
| The metabolic syndrome: should current criteria influence clinical practice? | Q36532716 | ||
| Metabolic syndrome: a solution in search of a problem | Q36729837 | ||
| Decreased muscle mass and increased central adiposity are independently related to mortality in older men | Q81573120 | ||
| Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease: a population-based study | Q43747863 | ||
| Physical activity and hemostatic and inflammatory variables in elderly men. | Q43961149 | ||
| An accurate risk score based on anthropometric, dietary, and lifestyle factors to predict the development of type 2 diabetes | Q44040130 | ||
| Biochemical measures in a population-based study: effect of fasting duration and time of day. | Q44134906 | ||
| The diabetes risk score: a practical tool to predict type 2 diabetes risk | Q44333486 | ||
| Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study | Q44513183 | ||
| Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus | Q44853673 | ||
| Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targets study. | Q45959391 | ||
| The myth of the metabolic syndrome | Q46605082 | ||
| Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus | Q46795016 | ||
| Plasma lipoproteins and apolipoproteins as predictors of cardiovascular risk and treatment benefit in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER). | Q46795019 | ||
| Does the new International Diabetes Federation definition of the metabolic syndrome predict CHD any more strongly than older definitions? Findings from the British Women's Heart and Health Study | Q46868484 | ||
| Metabolic syndrome increases the risk of ischemic stroke in women | Q48155652 | ||
| Impact of metabolic syndrome on atherosclerotic burden and cardiovascular prognosis. | Q51469746 | ||
| The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns. | Q51478010 | ||
| Metabolic syndrome and cardiovascular disease in older people: The cardiovascular health study. | Q51489866 | ||
| Twenty year follow-up of a cohort based in general practices in 24 British towns | Q57416376 | ||
| The design of a prospective study of pravastatin in the elderly at risk (PROSPER) | Q57653855 | ||
| Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report | Q63694274 | ||
| Metabolic syndrome as a risk factor for coronary heart disease and stroke: an 11-year prospective cohort in Taiwan community | Q80273496 | ||
| P433 | issue | 9628 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cardiovascular disease | Q389735 |
| metabolic syndrome | Q657193 | ||
| P304 | page(s) | 1927-1935 | |
| P577 | publication date | 2008-05-22 | |
| P1433 | published in | The Lancet | Q939416 |
| P1476 | title | Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies | |
| P478 | volume | 371 |
| Q42593443 | "The metabolic syndrome... is dead": these reports are an exaggeration |
| Q51245841 | A Prospective Cohort Study of Early-Pregnancy Risk Factors for Gestational Diabetes in Women with Polycystic Ovarian Syndrome. |
| Q37308797 | A cross-sectional relationship between vital capacity and metabolic syndrome and between vital capacity and diabetes in a sample Japanese population |
| Q33930199 | A prospective analysis of elevated fasting glucose levels and cognitive function in older people: results from PROSPER and the Rotterdam Study |
| Q35060076 | A routine biomarker-based risk prediction model for metabolic syndrome in urban Han Chinese population |
| Q92341075 | Age-specific diabetes risk by the number of metabolic syndrome components: a Korean nationwide cohort study |
| Q36159564 | Altered liver expression of genes involved in lipid and glucose metabolism in mice with partial IGF-1 deficiency: an experimental approach to metabolic syndrome |
| Q37725233 | An observational study on the association of nonalcoholic fatty liver disease and metabolic syndrome with gall stone disease requiring cholecystectomy |
| Q28392948 | Analysis of metabolic syndrome components in >15 000 african americans identifies pleiotropic variants: results from the population architecture using genomics and epidemiology study |
| Q83025936 | Ankle brachial index vs metabolic syndrome for risk prediction |
| Q46230616 | Are elevated circulating intercellular adhesion molecule 1 levels more strongly predictive of diabetes than vascular risk? Outcome of a prospective study in the elderly |
| Q33474334 | Are markers of inflammation more strongly associated with risk for fatal than for nonfatal vascular events? |
| Q35994619 | Arterial stiffness and influences of the metabolic syndrome: a cross-countries study |
| Q52318656 | Association analysis of multiple traits by an approach of combining P values. |
| Q36183112 | Association between IL-6 and related risk factors of metabolic syndrome and cardiovascular disease in young rats |
| Q45029098 | Association between metabolic syndrome and white matter lesions in middle-aged and elderly patients |
| Q36236163 | Association of Metabolic Syndrome with the Adiponectin to Homeostasis Model Assessment of Insulin Resistance Ratio |
| Q43699713 | Association of blood pressure control and metabolic syndrome with cardiovascular risk in elderly Japanese: JATOS study |
| Q35088582 | Association of cholecystectomy with metabolic syndrome in a Chinese population |
| Q34222283 | Association of metabolic syndrome with development of new-onset diabetes after transplantation. |
| Q58307131 | Association of neuropeptide Y gene rs16147 polymorphism with metabolic syndrome in patients with documented coronary artery disease |
| Q84774071 | Balancing the cardiometabolic benefits and risks of statins |
| Q33986931 | Basal ganglia morphology links the metabolic syndrome and depressive symptoms |
| Q93038267 | C reactive protein level as a marker for dyslipidaemia, diabetes and metabolic syndrome: results from the Korea National Health and Nutrition Examination Survey |
| Q39221135 | C-reactive protein and ageing. |
| Q38087380 | Calculating cardiac risk in obese adolescents before and after onset of lifestyle intervention |
| Q46198177 | Carbohydrate restriction has a more favorable impact on the metabolic syndrome than a low fat diet |
| Q36430309 | Cardiac remodeling and myocardial dysfunction in obese spontaneously hypertensive rats |
| Q37980497 | Cardiovascular metabolic syndrome: mediators involved in the pathophysiology from obesity to coronary heart disease |
| Q37069274 | Cardiovascular risk factors and coronary atherosclerosis in retired National Football League players. |
| Q96591266 | Causes, consequences, and treatment of metabolically unhealthy fat distribution |
| Q89664972 | Changes in metabolic syndrome and its components and the risk of type 2 diabetes: a nationwide cohort study |
| Q50151468 | Cholecystectomy as a risk factor of metabolic syndrome: from epidemiologic clues to biochemical mechanisms. |
| Q33734994 | Combined Effect of Initial and Longitudinal Increases in γ-Glutamyltransferase on Incident Metabolic Syndrome: ARIRANG Study. |
| Q55311990 | Comparing the inflammatory profiles for incidence of diabetes mellitus and cardiovascular diseases: a prospective study exploring the 'common soil' hypothesis. |
| Q36512836 | Comparison of the effect of the metabolic syndrome and multiple traditional cardiovascular risk factors on vascular function |
| Q89701449 | Composite diagnostic criteria are problematic for linking potentially distinct populations: the case of frailty |
| Q46491161 | Contrasting associations of insulin resistance with diabetes, cardiovascular disease and all-cause mortality in the elderly: PROSPER long-term follow-up |
| Q36864575 | Correlation Between the Severity of Diabetic Peripheral Polyneuropathy and Glycosylated Hemoglobin Levels: A Quantitative Study |
| Q37391912 | Deep analyses of the associations of a series of biomarkers with insulin resistance, metabolic syndrome, and diabetes risk in nondiabetic middle-aged and elderly individuals: results from a Chinese community-based study |
| Q58102155 | Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia |
| Q33860361 | Differential effects of Calca-derived peptides in male mice with diet-induced obesity |
| Q35072544 | Differential relationship between metabolic syndrome score and severity of coronary atherosclerosis as assessed by angiography in a non-diabetic and diabetic Korean population. |
| Q41608056 | Disparities in Cardiovascular Disease and Type 2 Diabetes Risk Factors in Blacks and Whites: Dissecting Racial Paradox of Metabolic Syndrome |
| Q37285705 | Divergent fifteen-year trends in traditional and cardiometabolic risk factors of cardiovascular diseases in the Seychelles |
| Q46200304 | Dysglycaemia in non-diabetic hypertensive patients: comparison of the impact of two different classifications of impaired fasting glucose on the cardiovascular risk profile |
| Q51296102 | Effect of high-dose atorvastatin on the cardiovascular risk associated with individual components of metabolic syndrome: a subanalysis of the Treating to New Targets (TNT) study. |
| Q37105236 | Effects of fenofibrate treatment on cardiovascular disease risk in 9,795 individuals with type 2 diabetes and various components of the metabolic syndrome: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study |
| Q53827450 | Establishing post mortem criteria for the metabolic syndrome: an autopsy based cross-sectional study. |
| Q36606167 | Establishment and application of a new diagnostic definition of metabolic syndrome in the Shantou region of southern China |
| Q84978295 | Evidence-based practice guideline for the treatment of CKD |
| Q39265993 | Exploring reasons for ethnic disparities in diet- and lifestyle-related chronic disease for Asian sub-groups in New Zealand: a scoping exercise |
| Q43096513 | Favorable glucose tolerance and lower prevalence of metabolic syndrome in offspring without diabetes mellitus of nonagenarian siblings: the Leiden longevity study |
| Q51523089 | First Trimester Maternal Glycated Hemoglobin and Sex Hormone-Binding Globulin Do Not Predict Third Trimester Glucose Intolerance of Pregnancy. |
| Q83427928 | Going beyond associative studies of psoriasis and cardiovascular disease |
| Q22306331 | Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association |
| Q92548783 | HDL cholesterol is an independent predictor of β-cell function decline and incident type 2 diabetes: A longitudinal study |
| Q35984531 | High-sensitivity C-reactive protein to detect metabolic syndrome in a centrally obese population: a cross-sectional analysis |
| Q34043089 | Hop and Acacia Phytochemicals Decreased Lipotoxicity in 3T3-L1 Adipocytes, db/db Mice, and Individuals with Metabolic Syndrome |
| Q31138509 | Hypertriglyceridemic waist might be an alternative to metabolic syndrome for predicting future diabetes mellitus |
| Q37399294 | Identification of cardiovascular risk components in urban Chinese with metabolic syndrome and application to coronary heart disease prediction: a longitudinal study |
| Q33505849 | Identifying primary care patients at risk for future diabetes and cardiovascular disease using electronic health records |
| Q34224453 | Impact of age and gender on the prevalence and prognostic importance of the metabolic syndrome and its components in Europeans. The MORGAM Prospective Cohort Project |
| Q37233172 | Impact of longitudinal status change in metabolic syndrome defined by two different criteria on new onset of type 2 diabetes in a general Japanese population: the Tanno-Sobetsu Study |
| Q34015104 | Impact of metabolic syndrome and its individual components on the presence and severity of angiographic coronary artery disease |
| Q37437179 | Impact of metabolic syndrome compared with impaired fasting glucose on the development of type 2 diabetes in a general Japanese population: the Hisayama study |
| Q45925272 | Impact of the metabolic syndrome and its individual components on risk and severity of coronary heart disease. |
| Q47147666 | Impaired Fasting Glucose Is the Major Determinant of the 20-Year Mortality Risk Associated With Metabolic Syndrome in Nondiabetic Patients With Stable Coronary Artery Disease |
| Q90171982 | Improving prevention strategies for cardiometabolic disease |
| Q58720808 | Inadequate dietary energy intake associates with higher prevalence of metabolic syndrome in different groups of hemodialysis patients: a clinical observational study in multiple dialysis centers |
| Q37649683 | Increased plasma DPP4 activity is an independent predictor of the onset of metabolic syndrome in Chinese over 4 years: result from the China National Diabetes and Metabolic Disorders Study |
| Q90314913 | Index or illusion: The case of frailty indices in the Health and Retirement Study |
| Q47289520 | Indications for Surgery for Obesity and Weight-Related Diseases: Position Statements from the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO). |
| Q36860517 | Influence of age on the prevalence and components of the metabolic syndrome and the association with cardiovascular disease |
| Q48199007 | Influence of metabolic syndrome and race on the relationship between intensive blood pressure control and cardiovascular outcomes in the SPRINT cohort |
| Q92081629 | Inhibition of endoplasmic reticulum stress ameliorates cardiovascular injury in a rat model of metabolic syndrome |
| Q34145851 | Insulin resistance and systemic inflammation, but not metabolic syndrome phenotype, predict 9 years mortality in older adults. |
| Q36898042 | Insulin resistance in type 1 diabetes: what is 'double diabetes' and what are the risks? |
| Q36664199 | Insulin resistance in women's health: why it matters and how to identify it |
| Q45330314 | Insulin resistance: a risk marker for disease and disability in the older person |
| Q28072410 | Insulin-like growth factor-1 deficiency and metabolic syndrome |
| Q47928682 | Interrelationships among physical activity, depression, homocysteine, and metabolic syndrome with special considerations by sex. |
| Q43272788 | Intrauterine growth restriction: no unifying risk factor for the metabolic syndrome in young adults |
| Q36182928 | Investigation of relationship of visceral body fat and inflammatory markers with metabolic syndrome and its components among apparently healthy individuals |
| Q33591012 | Is impaired energy regulation the core of the metabolic syndrome in various ethnic groups of the USA and Taiwan? |
| Q38174285 | Is statin-induced diabetes clinically relevant? A comprehensive review of the literature |
| Q45405897 | JIS definition identified more Malaysian adults with metabolic syndrome compared to the NCEP-ATP III and IDF criteria |
| Q36813570 | Joint Analysis of Multiple Traits in Rare Variant Association Studies |
| Q37129611 | Lack of association between glucocorticoid use and presence of the metabolic syndrome in patients with rheumatoid arthritis: a cross-sectional study. |
| Q42883293 | Leisure-time physical activity and metabolic syndrome plus depressive symptoms in the FIN-D2D survey |
| Q37067123 | Leptin predicts diabetes but not cardiovascular disease: results from a large prospective study in an elderly population |
| Q41203894 | Lipid levels and new-onset diabetes in a hypertensive population: the China Stroke Primary Prevention Trial |
| Q57213627 | Low urine pH affects the development of metabolic syndrome, associative with the increase of dyslipidemia and dysglycemia: Nationwide cross-sectional study (KNHANES 2013-2015) and a single-center retrospective cohort study |
| Q34746856 | Marginalisation and cardiovascular disease among rural Sami in Northern Norway: a population-based cross-sectional study |
| Q41532274 | Metabolic Syndrome and Cardiovascular Risk in Elderly Treated Hypertensive Patients |
| Q57303348 | Metabolic Syndrome and Ethnicity |
| Q24616159 | Metabolic complications of androgen deprivation therapy for prostate cancer |
| Q35982357 | Metabolic syndrome across Europe: different clusters of risk factors. |
| Q37022974 | Metabolic syndrome and all-cause and cardiovascular mortality in an Italian elderly population: the Progetto Veneto Anziani (Pro.V.A.) Study |
| Q51450946 | Metabolic syndrome and its components as predictors of stroke in middle-aged and elderly Chinese people. |
| Q37707409 | Metabolic syndrome as a risk factor for diabetes |
| Q37738743 | Metabolic syndrome associated with schizophrenia and atypical antipsychotics |
| Q51358862 | Metabolic syndrome defined by modified International Diabetes Federation criteria and type 2 diabetes mellitus risk: a 9-year follow-up among the aged in Finland. |
| Q36152722 | Metabolic syndrome does not improve the prediction of 5-year cardiovascular disease and total mortality over standard risk markers. Prospective population based study |
| Q35686352 | Metabolic syndrome in South Asians |
| Q37682237 | Metabolic syndrome in peritoneal dialysis patients: choice of diagnostic criteria and prognostic implications |
| Q31116097 | Metabolic syndrome in rheumatoid arthritis: case control study |
| Q37179951 | Metabolic syndrome in the offspring of centenarians: focus on prevalence, components, and adipokines |
| Q33928071 | Metabolic syndrome is associated with learning and recall impairment in middle age. |
| Q91906220 | Metabolic syndrome is associated with peripheral endothelial dysfunction amongst men |
| Q37374394 | Metabolic syndrome is independently associated with increased 20-year mortality in patients with stable coronary artery disease |
| Q93087387 | Metabolic syndrome rates in older patients with severe mental illness after five years of follow-up and the association with mortality |
| Q36163696 | Metabolic syndrome vs. its components for prediction of cardiovascular mortality: A cohort study in Chinese elderly adults |
| Q34595173 | Metabolic syndrome, chronic kidney disease, and cardiovascular disease: a dynamic and life-threatening triad. |
| Q51370876 | Metabolic syndrome, impaired fasting glucose and obesity, as predictors of incident diabetes in 14 120 hypertensive patients of ASCOT-BPLA: comparison of their relative predictability using a novel approach. |
| Q42731807 | Metabolic syndrome, obstructive sleep apnea, and continuous positive airway pressure: a weighty issue |
| Q34781573 | Metabolic syndrome--what is the clinical usefulness? |
| Q37982204 | Metabolic syndrome: definition and therapeutic implications |
| Q35047747 | Metabolic syndrome: definitions and controversies. |
| Q58730865 | Methods and results from the genome-wide association group at GAW20 |
| Q37350896 | Methotrexate therapy associates with reduced prevalence of the metabolic syndrome in rheumatoid arthritis patients over the age of 60- more than just an anti-inflammatory effect? A cross sectional study |
| Q34261514 | MultiPhen: joint model of multiple phenotypes can increase discovery in GWAS. |
| Q35314232 | No association of apolipoprotein B gene polymorphism and blood lipids in obese Egyptian subjects |
| Q38656281 | Obesity, metabolic syndrome and diabetic retinopathy: Beyond hyperglycemia |
| Q39848035 | Obesity-related hypertension: epidemiology, pathophysiology, and clinical management |
| Q43061638 | Obstructive sleep apnea and the metabolic syndrome. |
| Q35607087 | Opportunities for longitudinal data linkage in Scotland |
| Q35109379 | Peripheral blood gene expression profiles in metabolic syndrome, coronary artery disease and type 2 diabetes |
| Q37771647 | Physical health in schizophrenia: a challenge for antipsychotic therapy |
| Q34118474 | Plasma levels of high-density lipoprotein cholesterol and outcomes in pulmonary arterial hypertension |
| Q37434624 | Plasminogen Activator Inhibitor-1 and Diagnosis of the Metabolic Syndrome in a West African Population. |
| Q57606221 | Polycystic Ovary Syndrome |
| Q37028898 | Predictive models for type 2 diabetes onset in middle-aged subjects with the metabolic syndrome |
| Q33389734 | Presence of the metabolic syndrome is not a better predictor of cardiovascular disease than the sum of its components in HIV-infected individuals: data collection on adverse events of anti-HIV drugs (D:A:D) study |
| Q93063084 | Pretransplant Homeostasis Model Assessment of Insulin Resistance and Fasting Plasma Glucose Predict New-Onset Diabetes After Renal Transplant in Chinese Patients |
| Q64096303 | Pretransplant metabolic syndrome and its components predict post-transplantation diabetes mellitus in Chinese patients receiving a first renal transplant |
| Q64088092 | Prevalence and clinical characteristics of hypertension and metabolic syndrome in newly diagnosed patients with ketosis-onset diabetes: a cross-sectional study |
| Q33390774 | Prevalence of cardiovascular risk factors and the metabolic syndrome in middle-aged men and women in Gothenburg, Sweden |
| Q55516094 | Prevalence of metabolic syndrome risk factors and their relationships with renal function in Chinese centenarians. |
| Q28396378 | Prevalence of premorbid metabolic syndrome in Spanish adult workers using IDF and ATPIII diagnostic criteria: relationship with cardiovascular risk factors |
| Q55175944 | Preventing premature mortality in chronic diseases for South Asians in the UK and beyond. |
| Q55282400 | Progression of diabetes, heart disease, and stroke multimorbidity in middle-aged women: A 20-year cohort study. |
| Q36868309 | Prospective study of serum adiponectin and incident metabolic syndrome: the ARIRANG study |
| Q84667091 | Psoriasis may not be an independent risk factor for acute ischemic heart disease hospitalizations: results of a large population-based Dutch cohort |
| Q36082229 | Regardless of central obesity, metabolic syndrome is a significant predictor of type 2 diabetes in Japanese Americans |
| Q92707942 | Relationship between metabolic syndrome and its components and cardiovascular disease in middle-aged and elderly Chinese population: a national cross-sectional survey |
| Q54333432 | Relationship between type 2 diabetes mellitus and a novel polymorphism C698T in C5L2 in the Chinese Han population. |
| Q36351005 | Relationships between components of metabolic syndrome and coronary intravascular ultrasound atherosclerosis measures in women without obstructive coronary artery disease: the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation Study |
| Q50328391 | Retinopathy predicts progression of fasting plasma glucose: An Early Diabetes Intervention Program (EDIP) analysis |
| Q38077060 | Revisiting the links between glycaemia, diabetes and cardiovascular disease |
| Q35095114 | Risk assessment tools for identifying individuals at risk of developing type 2 diabetes |
| Q34594892 | Risk factors for type 2 diabetes in groups stratified according to metabolic syndrome: a 10-year follow-up of the Tromsø Study |
| Q38798338 | Risk factors that may modify the innate and adaptive immune responses in periodontal diseases |
| Q38149853 | SLE and metabolic syndrome |
| Q43035535 | Soluble Fas and Fas ligand in HIV/HCV coinfected patients and impact of HCV therapy |
| Q21257267 | Subhealth: definition, criteria for diagnosis and potential prevalence in the central region of China |
| Q34515118 | Supplementary use of HbA1c as hyperglycemic criterion to detect metabolic syndrome |
| Q37173369 | Targeting oxidized LDL improves insulin sensitivity and immune cell function in obese Rhesus macaques. |
| Q28385811 | The Relationship of Metabolic Syndrome with Stress, Coronary Heart Disease and Pulmonary Function--An Occupational Cohort-Based Study |
| Q55176078 | The association between frailty, the metabolic syndrome, and mortality over the lifespan. |
| Q44777672 | The association between obesity and acute myocardial infarction is age- and gender-dependent in a Japanese population |
| Q34527010 | The association of homocysteine with metabolic syndrome in a community-dwelling population: homocysteine might be concomitant with metabolic syndrome |
| Q64245557 | The association of metabolic syndrome components and diabetes mellitus: evidence from China National Stroke Screening and Prevention Project |
| Q39178086 | The associations between leukocyte, erythrocyte or platelet, and metabolic syndrome in different genders of Chinese |
| Q36842540 | The clinical value of metabolic syndrome and risks of cardiometabolic events and mortality in the elderly: the Rotterdam study |
| Q83576023 | The effect of antihypertensive agents in people at high risk of cardiovascular disease and diabetes: a view through smoke and mirrors |
| Q33569142 | The metabolic syndrome |
| Q42951120 | The metabolic syndrome as a predictor of incident diabetes and cardiovascular events in the Health 2000 Study |
| Q37691695 | The metabolic syndrome in cancer survivors. |
| Q39919146 | The metabolic syndrome: useful concept or clinical tool? Report of a WHO Expert Consultation |
| Q26767142 | The metabolic vascular syndrome - guide to an individualized treatment |
| Q43190449 | The rise and fall of the metabolic syndrome |
| Q35940422 | Treatment patterns and risk factor control in patients with and without metabolic syndrome in cardiac rehabilitation |
| Q34150357 | Trekking exercise promotes cardiovascular health and fitness benefits in older obese women |
| Q28281855 | Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies |
| Q43216549 | Triglyceride-to-HDL-cholesterol ratio and metabolic syndrome as contributors to cardiovascular risk in overweight patients. |
| Q40147590 | Understanding Risk in the Oldest Old: Frailty and the Metabolic Syndrome in a Chinese Community Sample Aged 90+ Years |
| Q91739083 | Using syndrome mining with the Health and Retirement Study to identify the deadliest and least deadly frailty syndromes |
| Q37340985 | Visceral obesity is not an independent risk factor of mortality in subjects over 65 years |
Search more.